| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |